To examine the binding specificity of steroid hormone-cytoplasmic receptor complexes to nuclei, binding of3H-dexamethasone (Dex)-liver, 3H-Dex-thymus and3H-dihydrotestosterone (DHT)-prostate receptor complexes to nuclei from liver, prostate, thymus, spleen and kidney was studied. It was observed that a significant amount of steroid-receptor complexes was bound to any nuclei used in the present study and the extent of the binding of receptor complexes to nuclei from homologous tissues was not always greater than that to nuclei from heterogenous tissues. However, a significant portion of the3H-Dex-liver and3H-DHT-prostate receptor complexes was not absorbed by nuclei from kidney, spleen and thymus, and the unabsorbed complexes were efficiently bound to liver and prostate nuclei. The results obtained indicate that two types of receptor complex with regard to nuclear binding were present in cytosols of liver and prostate one binds to nuclei from kidney, spleen, thymus, liver and prostate and the other does not bind to nuclei from kidney, spleen and thymus but does bind to nuclei of liver and prostate.
Synopsis
To examine the binding specificity of steroid hormone-cytoplasmic receptor complexes to nuclei, binding of3H-dexamethasone (Dex)-liver, 3H-Dex-thymus and3H-dihydrotestosterone (DHT)-prostate receptor complexes to nuclei from liver, prostate, thymus, spleen and kidney was studied. It was observed that a significant amount of steroid-receptor complexes was bound to any nuclei used in the present study and the extent of the binding of receptor complexes to nuclei from homologous tissues was not always greater than that to nuclei from heterogenous tissues. However, a significant portion of the3H-Dex-liver and3H-DHT-prostate receptor complexes was not absorbed by nuclei from kidney, spleen and thymus, and the unabsorbed complexes were efficiently bound to liver and prostate nuclei. The results obtained indicate that two types of receptor complex with regard to nuclear binding were present in cytosols of liver and prostate one binds to nuclei from kidney, spleen, thymus, liver and prostate and the other does not bind to nuclei from kidney, spleen and thymus but does bind to nuclei of liver and prostate.
The latter type of receptor complex was not observed in the cytosol from the thymus.
Translocation of the steroid hormonecytoplasmic receptor complex seems to be an obligatory step in the mechanism of steroid hormone action. However, many conflicting observations concerning the mode of binding of hormone-receptor complexes by nuclei have been reported. Lack of tissue specificity of the binding has been reported for the progesterone-receptor complex of chick oviduct (Buller et al., 1975; Jaffe et al., 1975) , the estrogen-receptor complex of rat uterus (Chamness et al., 1973) and also for the androgen-receptor complex of rat ventral prostate (Ichii, 1975) . On the other hand the interaction of glucocorticoid and liver cytosol with liver nuclei was postulated to be tissue specific (Milgrom and Atiger, 1975 ) and the enrichment of nuclear acceptor sites for the hormone-receptor complexes was observed in target tissues of progesterone (Jaffe et al., 1975), dihydrotestosterone (Fang and Liao, 1971) , estrogen (Danzo et al., 1978) and glucocorticoids (Turnell and Burton, 1975) . However, there have been other reports indicating that estrogen and androgen-receptor complexes bound to nuclei from various tissues in almost the same manner (Chamness et al., 1973; Ichii et al., 1977) . In this way, the physiological significance of the nuclear binding of cytoplasmic steroid hormonereceptor complexes in the mechanism of steroid hormone action is not yet fully. understood.
In the present study, we examined the nuclear binding specificity for steroid hormone-receptor complexes using of Burton (1956) and Lowry et al.(1951) , respectively. The radioactivity was determined in10ml of toluene counting fluid using a Tri-Carb liquid scintillation spectrometer with automatic external standardization for quenching correction.
Results
When3H-Dex-labelled liver cytosol was incubated either with kidney nuclei or with spleen nuclei, significant amounts of the radioactivity were recovered with nuclei as a bound form (Fig.1a) .
It required4 changes with fresh nuclei to minimize the binding components bound to such nuclei in the incubation mixture; after the4th treatment with nuclei, no significant binding to such nuclei was observed. Pretreated 3H-Dex-labelled liver cytosol with nuclei from kidney and spleen in this manner was finally incubated with liver nuclei. As seen in Fig.1a , a significant amount of the radioactivity in the pretreated labelled liver cytosol was bound to liver nuclei. This indicated that some portion of the cytoplasmic3H-Dex-liver receptor complex bound to liver nuclei was not bound to either kidney or spleen nuclei. Similarly, the3H-Dex-liver receptor complex was bound to thymus nuclei to a significant extent, but with thymus nuclei all of the liver complex was not removed from the incubation mixture; after the4th treatment with thymus nuclei, significant amount of the complex which has an ability to bind to liver nuclei still remained in the incubation mixture (Fig.1b) .
However, under the similar incubation conditions, prostate nuclei removed almost all the liver receptor complex from the reaction mixture (Fig.  1c) .
The receptor complex bound only to thymus nuclei was not observed. Almost all the3H-Dex-thymus receptor complex was eliminated from the incubation mixture by repeated treatments with nuclei from any tissues used in the present study ( Fig.  2a-c) .
On the other hand, the3H-DHT-prostate receptor complex was not removed completely from the reaction mixture by treatments with nuclei from thymus, kidney and spleen (Figs.3b and c) . However, treatments of the3H-DHT-labelled prostate cytosol with liver nuclei removed almost all the complex bound to prostate nuclei from the reaction mixture (Fig.3a) . et al.
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Japon Interaction of hormone-receptor complexes with nuclei seems to be a key step in the mechanism of steroid hormone action and many investigations have been performed on the nuclear binding of steroid hormone-receptor complexes in vitro. However, the mode of nuclear binding, of hormone-receptor complexes has been the subject of controversy for many years. Several groups have shown that nuclei from target tissues bind cytoplasmic receptors to a greater extent than do nuclei from nontarget tissues (Danzo et al., 1978; Fang and Liao, 1971; Geschwendt and Hamilton, 1972; Mushliner et al., 1970; Steggles et al., 1971; Turnell and Burton, 1975) . On the other hand, other investigators postulated that steroid hormone-receptor complexes bound almost equally to nuclei from various tissues (Buller et al., 1975; Chamness et al., 1973; Ichii, 1975; Yamamoto and Albert, 1975) .
In the present study, it was observed that the significant amount of steroid hormone-receptor complexes from liver, thymus and prostate bound to any nuclei from liver, prostate, kidney, spleen and thymus. Furthermore, the extent of binding to nuclei from homologous tissues was not always greater than that to nuclei from heterogenous tissues. However, it was found that the significant portion of the3H-Dex-liver receptor complex and that of the3H-DHTprostate receptor complex were not eliminated from the reaction mixture after extensive absorption with nuclei from kidney, spleen and thymus (Figs.1a, 1b, 3b and3c) . Heterogeneity of steroid hormone receptor was revealed in some tissues (Agarwal, 1975 Agarwal and Phillipe, 1977) , so it might be quite probable that the different component in preparations of steroid hormone-receptor complexes behaved differently in the nuclear binding. In the3H-Dex-labelled liver cytosol, some component (s) bound to nuclei from kidney, spleen and thymus but there was (were) observed other component (s) which did not bind to nuclei from kidney, spleen and thymus but did bind to nuclei from liver and prostate. The similar nuclear binding component (s) was (were) also observed in the preparation of3H-DHT-labelled prostate cytosol, which did not bind to nuclei from kidney, spleen and thymus but bound to nuclei from prostate and liver. To examine differences in physiological properties of receptor complexes which showed different characteristics of the nuclear binding, stimulation of RNA-polymerase in the rat ventral prostate by the DHT-prostate receptor complex was studied. However, Fig.3 this attempt was not successful, since, in our hand, no significant stimulation of RNApolymerase in the rat ventral prostate was obtained even with the DHT-prostate receptor complex which was not pretreated with heterogenous nuclei under the similar incubation conditions described by Davies and Griffiths (1973) (data not shown). Comparison of other properties of the receptor complex "absorbed" by heterogenous nuclei with those of the "unabsorbed" one in liver and prostate is under examination in this laboratory.
In the present study, any evidences for the presence of tissue-specific receptor complex with regard to the nuclear binding were not obtained. Therefore, a question how the great selectivity in receptor action is achieved despite an apparently weak selectivity in nuclear binding of receptor complexes has arisen. Since the interaction of hormone-receptor complexes with nuclei seems to be an obligatory step in the mechanism of steroid hormone action, this question has to be answered to gain further insight into the mechanism of steroid hormone action.
